Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 66342 |
Drug Identification Number | 02240285 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2ML X 10 VIALS |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-10-15 |
Estimated end date | 2018-12-17 |
Actual end date | 2019-01-07 |
Shortage status | Resolved |
Updated date | 2019-01-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-01-16 | French | Compare |
v3 | 2019-01-16 | English | Compare |
v2 | 2018-11-06 | French | Compare |
v1 | 2018-11-06 | English | Compare |
Showing 1 to 4 of 4